Academic Centers Compared With Nonacademic Centers for Patients With International Prognostic Index Risk-stratified Diffuse Large B-cell Lymphoma: A Survival Outcomes Analysis

Abstract

Diffuse large B-cell lymphoma is associated with varying outcomes, and disparities exist within high-risk disease. Prognostication with the International Prognostic Index anticipates patient outcomes, provides risk stratification, and guides treatment. We used a national database to compare the treatment outcomes from academic and nonacademic centers. We found improved overall survival in each risk category at academic centers.